Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-11-06
1994-07-05
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514267, 544231, 544283, A61K 31505, C07D40304
Patent
active
053267656
ABSTRACT:
Novel 2,2,4-trialkyl-1,2-dihydroquinazoline-3-oxides and their synthesis are described. These compounds possess cardiotonic activity, and are useful for the treatment of heart failure.
REFERENCES:
patent: 3398139 (1968-08-01), Field et al.
patent: 3485841 (1969-12-01), Field et al.
patent: 4963554 (1990-10-01), Combs et al.
Armarego, et al., "Journ. Chem. Soc." C, 1966, pp. 1433-1436.
Walker, et al., "Jour. Org. Chem.", vol. 37, No. 24, 1972 pp. 3755-3770.
Bandurco Victor
Combs Donald W.
Falotico Robert
Davis Zinna N.
Ivy C. Warren
Ortho Pharmaceutical Corporation
Palo Ralph R.
LandOfFree
2,2,4-trialkyl-1,2-dihydroquinazoline-3-oxides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,2,4-trialkyl-1,2-dihydroquinazoline-3-oxides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,2,4-trialkyl-1,2-dihydroquinazoline-3-oxides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-796130